Kant Drugs Private Limited

Kant Drugs Private Limited - pharma in Uttar Pradesh, Uttar Pradesh, India. FY 2026 financials and compliance.
CIN U24232UP2001PTC025855 Incorporated 05 February 2001 ROC Uttar Pradesh HQ Uttar Pradesh, Uttar Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2022
₹11.2 Cr
▲ 12.11% YoY
EBITDA · FY 2022
Locked
In full report
Net profit · FY 2022
Locked
In full report
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.15 Cr
Issued & subscribed
Open charges
₹4.24 Cr
Secured borrowings
Company age
25 yrs
Est. 2001
Employees · EPFO
57
Latest available

About Kant Drugs Private Limited

Data last updated: 13 March 2026

Kant Drugs Private Limited is a private limited company based in Uttar Pradesh, Uttar Pradesh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 05 February 2001, the company has been in operation for over 25 years.

Registered with ROC Uttar Pradesh under CIN U24232UP2001PTC025855.

Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.15 Cr. It is led by directors including Manoj Rastogi and Mehul Rastogi.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Bharat Ashramraja Bazar Lucknow, Uttar Pradesh, Uttar Pradesh, India – 226003.

As per the financials filed for FY 2022, the company reported a revenue of ₹11.2 Cr, a growth of 12.11% compared to the previous year.

The company has a workforce of approximately 57 employees as per the latest available data.

The company is associated with 1 brand - S Kant Healthcare. As per MCA filings, the company has open charges of ₹4.24 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Kant Drugs Private Limited
CIN U24232UP2001PTC025855
Registration Number 025855
Incorporation Date 05 February 2001
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Bharat Ashramraja Bazar Lucknow, Uttar Pradesh, Uttar Pradesh, India – 226003
  • Industry
    Pharma, Drug Formulation & Development
Company report
Kant Drugs Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Kant Drugs Private Limited report

Financials, compliance, directors, charges, ownership and filings for Kant Drugs Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Kant Drugs Private Limited

Kant Drugs Private Limited operates one associated brand: S Kant HEALTHCARE. These brands represent Kant Drugs Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufactures pharmaceutical formulations, APIs, conducts research, and exports products worldwide. skant.com

Competitors & Alternatives of Kant Drugs Private Limited

Brands and companies operating in the same space as Kant Drugs Private Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Kant Drugs Private Limited

Kant Drugs Private Limited operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Locked Manufacturing Locked Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Detailed business activity records for Kant Drugs Private Limited

Activity codes and turnover contribution percentages require an active report plan.

  • Activity group codes
  • Detailed activity codes
  • Turnover contribution

Verified entity values are shown only after access is granted.

Auditor Details of Kant Drugs Private Limited

Kant Drugs Private Limited is audited by KRISHNA RATAN & CO for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
KRISHNA RATAN & CO Locked Locked Locked
Premium access

Complete auditor history for Kant Drugs Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Kant Drugs Private Limited

Kant Drugs Private Limited is currently managed by 11 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Manoj Rastogi Director 05 Feb 2001 25 Years 5 Months Current
Mehul Rastogi Director 22 Sep 2015 10 Years 10 Months Current
Anurag Das Director 01 Mar 2010 16 Years 4 Months Current
Upasana Rastogi Director 15 Dec 2025 0 Years 7 Months Current
Manjulata Rastogi Director 15 Dec 2025 0 Years 7 Months Current
Bharati Patwari Rastogi Director 18 May 2021 5 Years 2 Months Current
Showing 6 of 11 current directors. View all directors

Financials of Kant Drugs Private Limited FY 2025 filings available

Kant Drugs Private Limited reported revenue of ₹11.2 Cr (up 12.11% YoY) for FY 2022.

Revenue · FY 2022
₹11.2 Cr ▲ 12.11%
Premium access

Ten-year financial statements for Kant Drugs Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Kant Drugs Private Limited

Premium access

Shareholding and ownership data for Kant Drugs Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Kant Drugs Private Limited

Open charges
₹4.24 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Hdfc Bank Limited₹4.24 Cr
Latest charge details
DateLenderAmountStatus
27 Aug 2021 Hdfc Bank Limited ₹99 Lakh Open
04 Jun 2016 Hdfc Bank Limited ₹3.25 Cr Open

Total charge records: 2 View all charges

Employees and EPFO Compliance at Kant Drugs Private Limited

Kant Drugs Private Limited has a workforce of 57 employees as of Apr 09, 2024.

Employee count
57
Active EPFO establishments
1
Employee growth
7.55%
Premium access

Employee and EPFO history for Kant Drugs Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Kant Drugs Private Limited

Premium access

GST registrations and filing compliance for Kant Drugs Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Kant Drugs Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Kant Drugs Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Kant Drugs Private Limited

Premium access

MSME payment history for Kant Drugs Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Kant Drugs Private Limited

Premium access

Corporate group structure for Kant Drugs Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Kant Drugs Private Limited

Premium access

MCA filings and documents for Kant Drugs Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Kant Drugs Private Limited

Directors
15 Dec 2025
Upasana Rastogi was appointed as a Director on 15 Dec 2025 & has been associated with this company since 7 months 10 days.
Directors
15 Dec 2025
Manjulata Rastogi was appointed as a Director on 15 Dec 2025 & has been associated with this company since 7 months 10 days.
Directors
15 Dec 2025
Ekta Rastogi was appointed as a Director on 15 Dec 2025 & has been associated with this company since 7 months 10 days.
Activity
30 Sep 2025
Kant Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Kant Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Charges
13 Aug 2023
A charge with Hdfc Bank Limited of Rs. 3.25 Cr registered on 04 Jun 2016 with Charge ID 100035012 was modified on 13 Aug 2023.

Frequently Asked Questions about Kant Drugs Private Limited

Kant Drugs Private Limited is an active private limited company in the pharma sector based in Uttar Pradesh, Uttar Pradesh, India. It was incorporated on 05 February 2001 (25+ years old) and is registered under CIN U24232UP2001PTC025855. The company has 57 employees.

Kant Drugs Private Limited reported revenue of ₹11.2 Cr for FY 2022 (up 12.11% YoY).

The current directors of Kant Drugs Private Limited are:

The primary industry of Kant Drugs Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Kant Drugs Private Limited can be reached at the registered office: Bharat Ashramraja Bazar Lucknow, Uttar Pradesh, Uttar Pradesh, India – 226003.

The authorised capital is ₹5 Cr, and the paid-up capital is ₹3.15 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available